Phyton Biotech is the world's largest producer of taxane active pharmaceutical ingredients. The company produces Paclitaxel and Docetaxel through Plant Cell Fermentation (PCF(R)). These plant-derived products are used in the treatment of cancer and other life-threatening illnesses. Phyton was founded in 1990 in Ithaca, New York, and was acquired in 2003 by DFB Pharmaceuticals, a private Texas-based investment company. The company's manufacturing facilities are located in Ahrensburg, Germany and Delta, Canada.